Insiders Palisade Bio, Inc.

Equities

SNCA

US6963894026

Market Closed - Nasdaq Other stock markets 21:00:00 16/05/2024 BST			5-day change	1st Jan Change
6.46 ^USD	+1.25%		-8.50%	-27.01%

05-10	Palisade Bio, Inc. announced that it has received $3.999943 million in funding	CI
05-07	Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors	05-07	CI
Palisade Bio, Inc. Announces Resignation of Mary Ann Gray as Member of the Board	03-06	CI
Palisade Bio Names Donald Williams as Chairman	02-13	MT
Palisade Bio, Inc. Announces Advisory Board Appointments	02-08	CI
Palisade Bio, Inc. Announces the Appointment of Mitchell Jones, M.D., Ph.D., as Chief Medical Officer	11/09/23	CI
Palisade Bio, Inc. Appoints Mitchell Jones as Chief Medical Officer	11/09/23	CI
Palisade Bio, Inc. Announces Board Appointments	08/02/23	CI
Palisade Bio Appoints Herbert B. Slade MD, FAAAAI as Chief Medical Officer	18/11/22	CI
Palisade Bio, Inc. Terminates Michael Dawson as Chief Medical Officer	17/10/22	CI
Palisade Bio, Inc. Announces Executive Changes	14/10/22	CI
Palisade Bio CEO Thomas Hallam Resigns; CFO JD Finley Named Interim Replacement; Shares Fall	11/10/22	MT
Palisade Bio, Inc. Announces Chief Executive Officer Changes	11/10/22	CI
Palisade Bio, Inc. Appoints Robert McRae as Senior Vice President, Operations and Strategic Development	15/02/22	CI
Palisade Bio, Inc. Launches Clinical Steering Committee	15/06/21	CI
Seneca Biopharma, Inc. Announces Board Changes	27/04/21	CI
Palisade Bio, Inc. Announces Board Changes	26/04/21	CI
Seneca Biopharma, Inc. Announces Appointment of Dane Saglio as Principal Executive Officer	18/03/21	CI
Seneca Biopharma, Inc. Announces Management Changes	18/03/21	CI
Thomas Hallam to Serve as Chief Executive Officer of Seneca Biopharma, Inc	21/12/20	CI
Seneca Biopharma, Inc. Announces Executive Appointments and Key Promotion	01/04/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Palisade Bio, Inc.

Equities

SNCA

US6963894026

Insiders

Filters